Evidence map›Paper›PMID 40777412›Full record

ArticlebioRxiv : the preprint server for biology2025

Deep-learning triage of 3D pathology datasets for comprehensive and efficient pathologist assessments.

Gan Gao, Renao Yan, Andrew H Song, Huai-Ching Hsieh, Lindsey A Erion Barner, Fiona Wang, David Brenes, Sarah S L Chow, Rui Wang, Kevin W Bishop and 13 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Gan GaoDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Renao YanDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Andrew H SongDepartment of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
Huai-Ching HsiehDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Lindsey A Erion BarnerDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Fiona WangDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
David BrenesDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Sarah S L ChowDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Rui WangDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Kevin W BishopDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Yongjun LiuDepartment of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA.
Xavier FarrePublic Health Agency of Catalonia, Lleida, Spain.
Mukul DivatiaDepartment of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA.
Michelle R DownesSunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Funda Vakar-LopezDepartment of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA.
Priti LalPathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Wynn BurkeDepartment of Medicine, University of Washington, Seattle, WA, USA.
Anant MadabhushiWallace H. Coulter Department of Biomedical Engineering, Emory University & Georgia Institute of Technology, Atlanta, GA, USA.
Lawrence D TrueDepartment of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA.
Deepti M ReddiDepartment of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA.
William M GradyDepartment of Medicine, University of Washington, Seattle, WA, USA.
Faisal MahmoodDepartment of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
Jonathan T C LiuDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.ORCID 0000-0001-5650-3086

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETER S NELSON · 2002 to 2026
$58.1M
Whole Exome Approaches for Esophageal Adenocarcinoma Susceptibility GenesU54CA163060 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI CHAK, AMITABH, GUDA, KISHORE · 2011 to 2022
$14.0M
Identify and validate novel epigenetic molecular markers for colorectal neoplasmU01CA152756 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY, GUDA, KISHORE · 2010 to 2021
$6.7M
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagusU2CCA271902 · NCI · FRED HUTCHINSON CANCER CENTER · PI Cecilia C Yeung · 2022 to 2026
$5.3M
Pathology CoreU54CA254566 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MADABHUSHI, ANANT · 2020 to 2024
$5.0M
Esophageal Cancer from Cells to Population: A Multiscale ApproachU01CA182940 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HUR, CHIN, INADOMI, JOHN MATTHEW · 2013 to 2017
$3.3M
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.R01CA220004 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY, HALBERG, RICHARD BROTT · 2017 to 2021
$3.2M
Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)R01CA249992 · NCI · EMORY UNIVERSITY · PI LEWIS, JAMES, MADABHUSHI, ANANT · 2021 to 2025
$3.2M
Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Prostate cancer risk stratification via computational 3D pathologyR01CA268207 · NCI · UNIVERSITY OF WASHINGTON · PI Jonathan T.C. Liu, Anant Madabhushi · 2022 to 2026
$3.1M
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
BLRD VA I01 BX004121BLRD VA IK6 BX006185NCI NIH HHS P50 CA097186NCI NIH HHS R01 CA202752NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220004NCI NIH HHS R01 CA220581NCI NIH HHS R01 CA249992NCI NIH HHS R01 CA257612NCI NIH HHS R01 CA268207NCI NIH HHS R01 CA268287NCI NIH HHS U01 CA152756NCI NIH HHS U01 CA182940NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226NCI NIH HHS U01 CA269181NCI NIH HHS U2C CA271902NCI NIH HHS U54 CA163060NCI NIH HHS U54 CA254566NIBIB NIH HHS R01 EB031002NIDDK NIH HHS R01 DK138948
6 · The paper itself

Abstract

Standard-of-care slide-based 2D histopathology severely undersamples spatially heterogeneous tissue specimens, with each thin 2D section representing <1% of the entire tissue volume (in the case of a biopsy). Recent advances in non-destructive 3D pathology, such as open-top light-sheet microscopy (OTLS), enable comprehensive high-resolution imaging of large clinical specimens. While fully automated computational analyses of such 3D pathology datasets are being explored, a potential low-risk route for accelerated clinical adoption would be to continue to rely upon pathologists to provide final diagnoses. Since manual review of these massive and complex 3D datasets is infeasible for routine clinical practice, we present CARP3D, a deep learning triage framework that identifies high-risk 2D cross sections within large 3D pathology datasets to enable time-efficient pathologist evaluation. CARP3D assigns risk scores to all 2D levels within a tissue volume by leveraging context from a subset of neighboring depth levels, outperforming models in which predictions are based on isolated 2D levels. In two use cases - risk stratification based on prostate cancer biopsies and screening for dysplasia/cancer in endoscopic biopsies of Barrett's esophagus - AI-triaged 3D pathology, enabled by CARP3D, demonstrates the potential to improve the detection of high-risk diseases in comparison to slide-based 2D histopathology while optimizing pathologist workloads.

Identifiers

PMID40777412
PMCPMC12330501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.